To The Moon

The main U.S. stock market indexes closed modestly higher on Wednesday, as easing government bond yields boosted risk appetite while a dramatic rally in shares of vaccine-maker Moderna drove gains in the healthcare sector.

Regarding the options market, a total volume of 63,899,336 contracts was traded, of which 60% were call options.

Top 10 Option Volumes

Top 10: $Tesla(TSLA)$, $NVIDIA(NVDA)$, $Apple(AAPL)$, $Amazon.com(AMZN)$, $Intel(INTC)$, $Micron Technology(MU)$, $Strategy(MSTR)$, $Microsoft(MSFT)$, $SpaceX(SPCX)$, $Meta Platforms(META)$

$Invesco QQQ Trust(QQQ)$ finished the session at $716.08, down 0.2%. Options flow showed notable institutional conviction despite the muted price action. The session was dominated by a $61.84 million same-side double-call buy and a $19.58 million out-of-the-money call purchase, both expiring in 2026. These trades reflect strong bullish positioning rather than passive premium selling, with traders committing significant net debit to gain leveraged upside exposure to QQQ.

Options Indicators

QQQ’s implied volatility is 22.28%, and with an IV percentile of 28.69%, current option volatility sits on the lower end of its historical range, indicating that options are relatively cheaply priced rather than expensive.

Large Trades

A directional same-side double-CALL buying combination with a net debit of $61.84 million was the largest highlighted trade, consisting of long 700.0 calls and long 705.0 calls expiring on 2026-08-31. With QQQ referenced at 716.08, both strikes were in the money at execution, which makes this structure a high-conviction bullish positioning rather than simple premium harvesting. Because this was a same-side double-buy CALL combination, the trader paid a substantial net debit to gain amplified upside exposure and to express a view that QQQ could make a meaningful directional move higher over a longer-dated horizon.

A CALL buy worth $19.58 million was the other standout trade, with the purchase of 11,311 contracts of the 717.0 strike expiring on 2026-09-18. This call was slightly out of the money versus the 716.08 reference price, so the position reflects a straightforward bullish bet on additional upside beyond current levels. The use of an out-of-the-money strike suggests the buyer was targeting continued appreciation with defined risk, using option premium to secure leveraged upside exposure into September 2026.

Overall, the bulk-order flow leaned bullish, the tone was shaped mainly by the very large net-debit call accumulation and reinforced by the sizable outright purchase of the 717 calls, showing traders were willing to spend significant premium for upside participation rather than merely sell volatility. While there was still meaningful bearish activity in the wider tape, the dominant character of the largest trades points to expectations for further upside in QQQ.

Unusual Options Activity

$Moderna(MRNA)$ closed at $174.38, rising 176.97%. MRNA options flow showed a heavily bearish tilt after huge rally, with the largest trades dominated by premium collection on upside calls and long-dated downside protection. A $525 thousand bear call spread and a $1.67 million put purchase stood out, while total bearish premium of $4.63 million dwarfed $632 thousand in bullish premium, leaving a $4.00 million net bearish imbalance.

Options Indicators

MRNA’s implied volatility is 139.12%, and with an IV percentile of 100.00%, current option volatility sits at the extreme high end of its historical range. Combined with an IV/HV ratio of 2.34, this indicates the options market is pricing in substantially more future movement than the stock has recently realized, leaving contracts in an elevated and expensive state from a volatility standpoint.

Large Trades

A PUT buy worth $1.67 million in the Mar. 19, 2027 $80 strike was the other highlighted large trade. This was a purchase of 2,000 out-of-the-money puts, making it a clearly bearish position that benefits from a substantial decline in MRNA over a longer-dated horizon. Because the strike sits far below the current stock price, the trade looks like either a downside hedge against major weakness or a low-strike speculative bearish bet on a deeper drawdown rather than a near-term tactical hedge around current levels.

A bear call spread collecting a net credit of $525 thousand was the largest featured combination trade, built by selling 1,500 Aug. 28, 2026 $135 calls and buying 1,500 Aug. 28, 2026 $145 calls. With MRNA referenced at $174.38, both strikes are in the money, and the structure reflects a defined-risk bearish call spread designed to collect premium while expressing the view that upside will remain capped below the spread’s upper region over time. The net credit points to a premium-collection strategy with a bearish bias rather than an outright high-conviction upside chase.

Overall, large-trade flow in MRNA was decisively bearish, with $4.63 million of bearish premium versus just $632 thousand of bullish premium, leaving a net bearish imbalance of $4.00 million. The directional takeaway is clearly negative: the dominant flows were a bearish premium-selling call spread and a sizable long-dated put purchase, while the bullish activity was limited to smaller put sales. That mix suggests institutions were more focused on capping upside and positioning for downside risk than on building constructive exposure.

Earn $30 Worth Rewards, Capture Potential Opportunities With Options!